Foley & Lardner represented CECO Environmental Corp. in the transaction. CECO Environmental Corp. announced the negotiation of its agreement to acquire Profire Energy, Inc., a leader...
You must be a Standard 1 Year member to access this content.
Foley & Larder LLP represented TCG Crossover, lead investor. Adverum Biotechnologies has agreed to sell approximately 106.25 million shares of its common stock at a price per share...
You must be a Standard 1 Year member to access this content.
Foley & Larder LLP represented investor TCG Crossover. Silence Therapeutics plc (Nasdaq: SLN), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing...
You must be a Standard 1 Year member to access this content.
Foley & Larder LLP represented TCG Crossover, as lead investor. Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension,...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented TCGX as a lead investor in the financing of COMPASS Pathways. COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented TCG Crossover on the deal. TCG Crossover acted as the lead investor in KalVista Pharmaceuticals’ $58 million registered direct offering. KalVista...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised LoftyInc Capital on the deal. LoftyInc Capital, a pan-African VC firm, announced the launch of its third fund – LoftyInc Afropreneurs Fund 3...
You must be a Standard 1 Year member to access this content.
